Drawing for MOLECULE.ONE

USPTO serial 79283424

MOLECULE.ONE

Reviewed by CopyMark Law Group

Reg. 6897465Status 700Registered
Filing date
Status date
Registration date
Nov 15, 2022
Examiner
XU, ELAINE YILIN
Law office
TMO LAW OFFICE 127

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MOLECULE.ONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter J. Rosene

Peter J. Rosene McBrayer PLLC500 W. Jefferson Street, Suite 2400Louisville, KY 40202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for use in data analysis in the field of medicine; Downloadable Computer software for use in systems to support medical decision-making; Humanoid robots with artificial intelligence; Downloadable Software based on artificial intelligence technology for use in designing synthesis paths; Downloadable Computer software for use in data analysis capable of understanding and analyzing human questions and formulating answers to these questions; Downloadable computer program to support decision making process in the field of medicine and pharmacy, which is based on artificial intelligenceACTIVE—
042Design, installation, updating and rental of computer software for use in the field of medicine and pharmacy; Design, installation, updating and implementation of computer software capable of understanding and analyzing human questions and formulating answers to these questions; Development of computer vision algorithms being a type of software development service; Design and development of computer software in the fields of artificial intelligence, deep learning, distributed computing, virtualization and machine learning; Research, design and development services of computer software relating to pharmaceutical products data processing by computer vision; providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for use in machine learning at the initial, being early, drug discovery stage; Creating software enabling the design of synthesis paths for organic compounds taking into account the creator's preferences; Providing online non-downloadable software for the design of synthesis pathwaysACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 19, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 8, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 7, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 15, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 15, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 30, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 28, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 28, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jul 28, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 28, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 28, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 1, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 1, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 1, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 21, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 22, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 21, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 24, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Nov 24, 2020CNSLSUSPENSION LETTER WRITTEN—
Nov 6, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 5, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 5, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2020RFNTREFUSAL PROCESSED BY IB—
May 8, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 8, 2020RFRRREFUSAL PROCESSED BY MPU—
Apr 25, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 24, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 17, 2020DOCKASSIGNED TO EXAMINER—
Apr 17, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance